Halozyme Therapeutics
HALO
#1816
Rank
A$17.20 B
Marketcap
A$145.06
Share price
-0.69%
Change (1 day)
50.34%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2026 (TTM): A$0.75 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are A$1.50 Billion. In 2025 the company made an earning of A$0.66 Billion a decrease over its 2024 earnings that were of A$0.78 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.75 B13.83%
2025 A$0.66 B-16.2%
2024 A$0.78 B59.94%
2023 A$0.49 B39.94%
2022 A$0.35 B0.16%
2021 A$0.35 B92.2%
2020 A$0.18 B-278.96%
2019 -A$0.11 Billion-9.45%
2018 -A$0.12 Billion-229.51%
2017 A$87.27 M-160.48%
2016 -A$0.15 Billion216.03%
2015 -A$45.66 Million-52.86%
2014 -A$96.86 Million-18.09%
2013 -A$0.12 Billion55.88%
2012 -A$75.86 Million169.94%
2011 -A$28.11 Million-63.44%
2010 -A$76.86 Million-7.19%
2009 -A$82.81 Million15.91%
2008 -A$71.45 Million83.89%
2007 -A$38.86 Million78.1%
2006 -A$21.82 Million16%
2005 -A$18.81 Million45.24%
2004 -A$12.95 Million682.42%
2003 -A$1.66 Million1659.12%
2002 -A$0.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$36.79 B 5,060.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$15.00 B 2,004.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$44.08 B 6,083.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$10.84 B 1,421.43%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-A$0.72 Billion-200.92%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-A$40.48 Million-105.68%๐Ÿ‡บ๐Ÿ‡ธ USA